Go Pro
→ A $5 stock inside Kennedy Space Center? (From Freedom Financial) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$4.16
-0.5%		$4.31
$3.28
▼
$6.18
$539.82M1.17742,643 shs1.43 million shs
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$8.57
-8.6%		$8.80
$5.37
▼
$17.58
$612.09M1.78864,767 shs1.73 million shs
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$101.01
-1.6%		$100.31
$58.83
▼
$113.99
$574.25M0.92152,058 shs85,138 shs
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
$0.76
-0.2%		$0.92
$0.69
▼
$3.10
$164.74M3.242.66 million shs1.45 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-2.34%-4.57%-9.52%-15.04%+7.73%
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-0.12%+22.98%-7.30%-9.44%-34.44%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
+1.46%+2.97%+0.06%-3.30%+78.66%
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
-1.16%+7.72%-20.51%-22.85%-47.47%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$4.16
-0.5%		$4.31
$3.28
▼
$6.18
$539.82M1.17742,643 shs1.43 million shs
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$8.57
-8.6%		$8.80
$5.37
▼
$17.58
$612.09M1.78864,767 shs1.73 million shs
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$101.01
-1.6%		$100.31
$58.83
▼
$113.99
$574.25M0.92152,058 shs85,138 shs
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
$0.76
-0.2%		$0.92
$0.69
▼
$3.10
$164.74M3.242.66 million shs1.45 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-2.34%-4.57%-9.52%-15.04%+7.73%
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-0.12%+22.98%-7.30%-9.44%-34.44%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
+1.46%+2.97%+0.06%-3.30%+78.66%
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
-1.16%+7.72%-20.51%-22.85%-47.47%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
2.33
Hold$5.6936.72% Upside
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
1.67
Reduce$8.50-0.76% Downside
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
1.67
Reduce$94.00-6.94% Downside
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
1.50
Reduce$1.0032.45% Upside

Current Analyst Ratings Breakdown

Latest QSI, MLAB, CTKB, and DNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/21/2026
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/17/2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/8/2026
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
6/24/2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
6/24/2026
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
6/3/2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D+) ➝ Sell (D)
5/13/2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Stephens logo
Stephens
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$5.50 ➝ $4.75
5/12/2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$6.00 ➝ $5.50
(Data available from 8/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$201.49M2.67N/AN/A$2.67 per share1.56
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$170.15M3.29N/AN/A$8.74 per share0.98
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$249.13M2.27$11.58 per share8.72$33.71 per share3.00
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
$2.44M67.38N/AN/A$1.02 per share0.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$66.54M-$0.62N/A208.00N/A-38.98%-12.16%-9.07%N/A
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$312.76M-$5.36N/AN/AN/A-215.41%-56.08%-26.06%N/A
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$6.71M$1.2084.18N/AN/A2.69%20.96%8.78%8/10/2026 (Estimated)
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
-$101.34M-$0.51N/AN/AN/A-5,605.88%-47.35%-42.66%8/13/2026 (Estimated)

Latest QSI, MLAB, CTKB, and DNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
-$0.13N/AN/AN/A$0.30 millionN/A
8/10/2026Q1 2027
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$2.63N/AN/AN/A$60.87 millionN/A
8/5/2026Q2 2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.0933-$0.09+$0.0033-$0.09$47.31 million$48.14 million
8/5/2026Q2 2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$0.8950-$0.75+$0.1450-$0.75$24.05 million$20.16 million
5/27/2026Q4 2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$1.78$1.53-$0.25-$0.75$65.21 million$63.72 million
5/7/2026Q1 2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.08-$0.15-$0.07-$0.15$44.23 million$44.14 million
5/7/2026Q1 2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$1.2112-$1.39-$0.1789-$1.39$42.93 million$19.00 million
5/7/2026Q1 2026
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
-$0.12-$0.10+$0.02-$0.10$0.30 million$0.26 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/AN/AN/AN/AN/A
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
N/AN/AN/AN/AN/A
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$0.640.63%N/A53.33%N/A
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
N/AN/AN/AN/AN/A

Latest QSI, MLAB, CTKB, and DNA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/6/2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
quarterly$0.160.62%8/31/20268/31/20269/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/A
4.69
4.07
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
N/A
5.15
5.15
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
0.78
1.72
1.29
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
N/A
12.60
12.40

Institutional Ownership

CompanyInstitutional Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
69.46%
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
78.63%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
90.60%
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
39.90%

Insider Ownership

CompanyInsider Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
10.36%
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
12.69%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
2.80%
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
22.04%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
500129.14 million115.76 millionOptionable
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
64065.32 million57.03 millionOptionable
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
6805.60 million5.44 millionNot Optionable
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
150217.76 million169.77 millionOptionable

Recent News About These Companies

Quantum-Si (QSI) to Release Earnings on Tuesday
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/quantum-si-qsi-to-release-earnings-on-tuesday-2026-07-28/
Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026
July 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/27/3333857/0/en/quantum-si-to-report-second-quarter-2026-financial-results-on-august-13-2026.html
Quantum-Si (NASDAQ:QSI) Stock Price Down 0.5% - Should You Sell?
July 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/quantum-si-nasdaqqsi-stock-price-down-05-should-you-sell-2026-07-16/
Why Quantum-Si incorporated’s (QSI) Stock Is Up 5.02%
July 1, 2026  |  aaii.comA
Quantum-Si (NASDAQ:QSI) CEO Jeffrey Alan Hawkins Sells 11,311 Shares
June 25, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-qsi-insider-buying-and-selling-2026-06-25/
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 16, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260615141588/en/quantum-si-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4/
Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™
June 10, 2026  |  rutlandherald.comR
Why Quantum-Si incorporated’s (QSI) Stock Is Down 7.81%
June 8, 2026  |  aaii.comA
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
June 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/quantum-si-announces-expansion-proteus-120000670.html
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
June 3, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260602203644/en/quantum-si-announces-the-expansion-of-the-proteus%e2%84%a2-roadshow/
Is Quantum-Si (NASDAQ:QSI) In A Good Position To Invest In Growth?
June 1, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/quantum-si-nasdaq-qsi-good-121705721.html
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
May 15, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4905372-quantum-si-incorporated-qsi-shareholder-analyst-call-prepared-remarks-transcript
Alliance Global Partners Sticks to Its Buy Rating for Quantum-Si (QSI)
May 14, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/QSI/pressreleases/1826075/alliance-global-partners-sticks-to-its-buy-rating-for-quantum-si-qsi/
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 13, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260513832313/en/quantum-si-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4/
Quantum-Si Earnings Call: Proteus Progress, Profits Pending
May 8, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/quantum-si-earnings-call-proteus-progress-profits-pending?utm_source=marketbeat.com&utm_medium=referral
Quantum-Si Incorporated (QSI) Reports Q1 Loss, Misses Revenue Estimates
May 7, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2917611/quantum-si-incorporated-qsi-reports-q1-loss-misses-revenue-estimates?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_4-2917611
Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones
May 7, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260507483844/en/quantum-si-reports-first-quarter-2026-financial-results-and-highlights-proteus%e2%84%a2-development-milestones/
Earnings To Watch: Quantum-Si Inc (QSI) Reports Q1 2026 Result
May 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/earnings-watch-quantum-si-inc-133347972.html
Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 1, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/05/01/10375319.htm
Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments
April 30, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/04/28/10372479.htm
Jeffry Keyes Sells 37,381 Shares of Quantum-Si (NASDAQ:QSI) Stock
April 23, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-qsi-insider-buying-and-selling-2026-04-23/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cytek Biosciences stock logo

Cytek Biosciences NASDAQ:CTKB

$4.16 -0.02 (-0.48%)
Closing price 04:00 PM Eastern
Extended Trading
$4.18 +0.02 (+0.55%)
As of 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Ginkgo Bioworks stock logo

Ginkgo Bioworks NYSE:DNA

$8.56 -0.81 (-8.59%)
Closing price 03:59 PM Eastern
Extended Trading
$8.54 -0.02 (-0.23%)
As of 06:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Mesa Laboratories stock logo

Mesa Laboratories NASDAQ:MLAB

$101.01 -1.61 (-1.57%)
Closing price 04:00 PM Eastern
Extended Trading
$100.89 -0.12 (-0.12%)
As of 05:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Quantum-Si stock logo

Quantum-Si NASDAQ:QSI

$0.76 0.00 (-0.20%)
Closing price 04:00 PM Eastern
Extended Trading
$0.77 +0.01 (+1.59%)
As of 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas